​

InnovAge (INNV) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

INNV Stock Forecast

InnovAge (INNV) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $6.80, with a high of $8.00 and a low of $5.00. This represents a 47.19% increase from the last price of $4.62.

$3 $4 $5 $6 $7 $8 High: $8 Avg: $6.8 Low: $5 Last Closed Price: $4.62

INNV Stock Rating

InnovAge stock's rating consensus is Hold, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (12.50%), 5 Hold (62.50%), 2 Sell (25.00%), and 0 Strong Sell (0.00%).

Hold
Total 8 2 5 1 0 Strong Sell Sell Hold Buy Strong Buy

INNV Price Target Upside V Benchmarks

TypeNameUpside
StockInnovAge47.19%
SectorHealthcare Stocks 13.55%
IndustryMedical Care Facilities Stocks12.78%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$4.62$4.62$4.62
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 25--3-14
Aug, 25--3-14
Jul, 25--3-14
Jun, 25--3-14
May, 25--3-14
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 08, 2023J.P. Morgan$8.00$7.506.67%73.16%
Nov 23, 2022Goldman Sachs$8.00$6.8017.65%73.16%
Nov 16, 2022Citigroup$8.00$7.2510.34%73.16%
Sep 15, 2022Barclays$5.00$4.941.21%8.23%
Apr 20, 2022Piper Sandler$5.00$6.59-24.13%8.23%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 10, 2024KeyBancSector Weightinitialise
Nov 23, 2022Goldman SachsNeutralNeutralhold
Nov 16, 2022CitigroupNeutralNeutralhold
Dec 28, 2021Goldman SachsNeutraldowngrade
Dec 27, 2021BarclaysEqual-Weightdowngrade

Financial Forecast

EPS Forecast

Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27
Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27
Reported$-0.33$-0.06$-0.30$-0.16$-0.22--
Avg Forecast$-0.24$0.06$-0.26$-0.17$-0.07$0.06$0.21
High Forecast$-0.24$0.06$-0.26$-0.15$-0.03$0.09$0.27
Low Forecast$-0.24$0.06$-0.26$-0.18$-0.09$0.04$0.14
Surprise %37.50%-200.00%15.38%-5.88%214.29%--

Revenue Forecast

$600M $700M $800M $900M $1B $1B Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27
Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27
Reported$637.80M$698.64M$688.09M$763.86M$853.70M--
Avg Forecast$633.89M$698.95M$686.11M$756.16M$848.69M$935.69M$1.06B
High Forecast$638.94M$704.51M$693.36M$757.12M$849.33M$938.99M$1.06B
Low Forecast$629.06M$693.61M$682.47M$755.20M$848.03M$932.94M$1.06B
Surprise %0.62%-0.04%0.29%1.02%0.59%--

Net Income Forecast

$-45M $-28M $-11M $6M $23M $40M Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27
Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27
Reported$-44.74M$-7.96M$-40.67M$-21.34M$-30.31M--
Avg Forecast$-32.58M$7.79M$-35.38M$-22.76M$-9.38M$8.60M$27.99M
High Forecast$-32.26M$7.87M$-35.13M$-20.69M$-4.62M$11.56M$36.69M
Low Forecast$-32.92M$7.71M$-35.86M$-24.83M$-12.33M$5.78M$19.06M
Surprise %37.33%-202.16%14.97%-6.25%223.22%--

INNV Forecast FAQ

Is InnovAge stock a buy?

InnovAge stock has a consensus rating of Hold, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 5 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that InnovAge is a neutral investment for most analysts.

What is InnovAge's price target?

InnovAge's price target, set by 8 Wall Street analysts, averages $6.8 over the next 12 months. The price target range spans from $5 at the low end to $8 at the high end, suggesting a potential 47.19% change from the previous closing price of $4.62.

How does InnovAge stock forecast compare to its benchmarks?

InnovAge's stock forecast shows a 47.19% upside, outperforming the average forecast for the healthcare stocks sector (13.55%) and outperforming the medical care facilities stocks industry (12.78%).

What is the breakdown of analyst ratings for InnovAge over the past three months?

  • September 2025: 0% Strong Buy, 0% Buy, 75.00% Hold, 0% Sell, 25.00% Strong Sell.
  • August 2025: 0% Strong Buy, 0% Buy, 75.00% Hold, 0% Sell, 25.00% Strong Sell.
  • July 2025: 0% Strong Buy, 0% Buy, 75.00% Hold, 0% Sell, 25.00% Strong Sell.

What is InnovAge’s EPS forecast?

InnovAge's average annual EPS forecast for its fiscal year ending in June 2026 is $0.06, marking a -127.27% decrease from the reported $-0.22 in 2025. Estimates for the following years are.

What is InnovAge’s revenue forecast?

InnovAge's average annual revenue forecast for its fiscal year ending in June 2026 is $935.69M, reflecting a 9.60% increase from the reported $853.7M in 2025. The forecast for.

What is InnovAge’s net income forecast?

InnovAge's net income forecast for the fiscal year ending in June 2026 stands at $8.6M, representing a -128.37% decrease from the reported $-30.313M in 2025. Projections indicate .